US2012220033A1PendingUtilityA1

Inhibition of viral gene expression using small interfering rna

50
Assignee: KASPAR ROGER LPriority: Sep 10, 2004Filed: Jan 27, 2012Published: Aug 30, 2012
Est. expirySep 10, 2024(expired)· nominal 20-yr term from priority
A61P 31/14C12N 2310/14A61P 1/16C12N 15/1131C12N 2770/24211C12N 2310/53C12N 2310/111C12N 2770/36111
50
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The invention provides methods, compositions, and kits comprising small interfering RNA (shRNA or siRNA) that are useful for inhibition of viral-mediated gene expression. Small interfering RNAs as described herein can be used in methods of treatment of HCV infection. ShRNA and siRNA constructs targetING the internal ribosome entry site (IRES) sequence of HCV are described.

Claims

exact text as granted — not AI-modified
1 . An RNA sequence consisting of
 a. a first RNA sequence, wherein the first RNA sequence is SEQ ID NO:34, (SEQ ID NO:35), (SEQ ID NO:36), (SEQ ID NO:37), (SEQ ID NO:38), (SEQ ID NO:39), (SEQ ID NO:40), (SEQ ID NO:41), (SEQ ID NO:42), (SEQ ID NO:43), (SEQ ID NO:44), (SEQ ID NO:45), (SEQ ID NO:46), (SEQ ID NO:47), (SEQ ID NO:48), (SEQ ID NO:49), (SEQ ID NO:50), (SEQ ID NO:51); (SEQ ID NO:52), (SEQ ID NO:53), (SEQ ID NO:54), (SEQ ID NO:55), (SEQ ID NO:56), or a sequence that differs from a foregoing sequence by one, two, or three nucleotides;   b. a second RNA sequence that is a complement of the first sequence;   c. a loop sequence positioned between the first and second nucleic acid sequence, the loop sequence consisting of 4-10 nucleotides; and   d. optionally, a two nucleotide overhang.   
     
     
         2 .- 17 . (canceled) 
     
     
         18 . A method of inhibiting expression or activity of a hepatitis C virus, the method comprising
 a. providing a cell that can express a hepatitis C virus; and   b. contacting the cell with an RNA sequence of  claim 1 .   
     
     
         19 - 61 . (canceled)

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.